- Report
- January 2024
- 175 Pages
Global
From €4750EUR$5,000USD£4,086GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4703EUR$4,950USD£4,045GBP
- Report
- March 2024
- 199 Pages
Global
From €3205EUR$3,374USD£2,757GBP
€3562EUR$3,749USD£3,064GBP
- Report
- May 2024
- 188 Pages
Global
From €5178EUR$5,450USD£4,454GBP
- Report
- November 2023
- 250 Pages
Global
From €4750EUR$5,000USD£4,086GBP
- Report
- January 2022
- 60 Pages
Global
From €3753EUR$3,950USD£3,228GBP
- Report
- April 2024
- 132 Pages
Global
From €903EUR$950USD£776GBP
- Book
- August 2019
- 264 Pages
- Book
- April 2019
- 328 Pages
Peripheral Arterial Disease (PAD) is a cardiovascular condition characterized by a narrowing of the arteries that supply blood to the limbs. It is caused by a buildup of plaque in the arteries, which can lead to a decrease in blood flow and oxygen to the legs and feet. Symptoms of PAD include pain in the legs and feet, numbness, and a decrease in the ability to walk. PAD is a major cause of disability and can lead to serious complications such as stroke, heart attack, and amputation. Treatment for PAD includes lifestyle changes, medications, and surgery.
The PAD market is a subset of the larger cardiology market, which includes treatments for a variety of cardiovascular conditions. Companies in the PAD market include Abbott, Boston Scientific, Medtronic, and Johnson & Johnson. These companies offer a range of products and services, including diagnostic tests, medical devices, and pharmaceuticals. Show Less Read more